Similarly, targeting signaling pathways that promote AMPAR exocytosis, such as PKA, ERK, and PI3K/Akt pathways, may offer therapeutic benefits in neurodegenerative disorders, including AD and HD [102, 260–262]. The gene discussed is AKT1; the disease is Huntington disease.